Breast Cancer Clinical Trials in Boston

Showing 481-500 of 598 trials

Vaccine Therapy in Treating Patients With Metastatic Breast Cancer

NCT00003761

This protocol is designed to evaluate the side effects of rV-DF3/MUC1 and to determine the safest dose which should be used in the treatment of breast cancer.

Breast Cancer

Dana-Farber Cancer Institute20 participantsStarted Mar 1999

Boston, Massachusetts, United States • Boston, Massachusetts, United States • Boston, Massachusetts, United States +1 more locations

COMPLETEDPhase 2< 1 mile

Novel Epothilone (BMS-247550) in Patients With Metastatic Breast Cancer (MBC)

NCT00080262

The purpose of this research study is to assess the response rate of the investigational drug BMS-247550 (Ixabepilone) in women with metastatic breast cancer who are refractory to an anthracycline, a taxane, and capecitabine.

Breast CancerMetastases

R-Pharm125 participantsStarted Feb 2004

La Verne, California, United States • Meriden, Connecticut, United States • Jacksonville, Florida, United States +42 more locations

Vaccine Therapy in Treating Patients With Metastatic Breast Cancer

Novel Epothilone (BMS-247550) in Patients With Metastatic Breast Cancer (MBC)

Breast Cancer Trials in Other Cities

Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast Cancer

A Study of PI3-Kinase Inhibitor GDC-0941 in Combination With Paclitaxel, With and Without Bevacizumab or Trastuzumab, and With Letrozole, in Participants With Locally Recurrent or Metastatic Breast Cancer

A Study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Breast Cancer Who Have Received at Least Two Prior Regimens of HER2-directed Therapy

A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers

Preoperative Cisplatin in Early Stage Breast Cancer

Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer

Breast MRI for Newly Diagnosed Breast Cancer:Impact on Re-excision Lumpectomy

Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer

Effect of the LIVESTRONG at the YMCA Exercise Program on Cancer Related Outcomes in Cancer Survivors

Exercise Intervention in Women With Metastatic Breast Cancer

Effects of Exercise Intervention on Insulin Levels in Breast Cancer Survivors

A Study of Trastuzumab Emtansine, Paclitaxel, and Pertuzumab in Patients With HER2-Positive, Locally Advanced or Metastatic Breast Cancer

Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer

Patient Perception of Mammogram Guidelines

Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02

A Study of Trastuzumab Emtansine in Patients With HER2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function

Phase I, Dose Study to Look at the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours

A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors

Other Conditions in Boston